222 related articles for article (PubMed ID: 22874667)
1. S-nitrosylation of Cdk5: potential implications in amyloid-β-related neurotoxicity in Alzheimer disease.
Qu J; Nakamura T; Holland EA; McKercher SR; Lipton SA
Prion; 2012; 6(4):364-70. PubMed ID: 22874667
[TBL] [Abstract][Full Text] [Related]
2. S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.
Qu J; Nakamura T; Cao G; Holland EA; McKercher SR; Lipton SA
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14330-5. PubMed ID: 21844361
[TBL] [Abstract][Full Text] [Related]
3. The role of Cdk5-mediated Drp1 phosphorylation in Aβ
Guo MY; Shang L; Hu YY; Jiang LP; Wan YY; Zhou QQ; Zhang K; Liao HF; Yi JL; Han XJ
J Cell Biochem; 2018 Jun; 119(6):4815-4825. PubMed ID: 29345339
[TBL] [Abstract][Full Text] [Related]
4. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.
Haun F; Nakamura T; Shiu AD; Cho DH; Tsunemi T; Holland EA; La Spada AR; Lipton SA
Antioxid Redox Signal; 2013 Oct; 19(11):1173-84. PubMed ID: 23641925
[TBL] [Abstract][Full Text] [Related]
5. Disruption of neuronal nitric oxide synthase dimerization contributes to the development of Alzheimer's disease: Involvement of cyclin-dependent kinase 5-mediated phosphorylation of neuronal nitric oxide synthase at Ser(293).
Kwon KJ; Park JH; Jo I; Song KH; Han JS; Park SH; Han SH; Cho DH
Neurochem Int; 2016 Oct; 99():52-61. PubMed ID: 27296112
[TBL] [Abstract][Full Text] [Related]
6. The Role of Cdk5 in Alzheimer's Disease.
Liu SL; Wang C; Jiang T; Tan L; Xing A; Yu JT
Mol Neurobiol; 2016 Sep; 53(7):4328-42. PubMed ID: 26227906
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization.
Lapresa R; Agulla J; Sánchez-Morán I; Zamarreño R; Prieto E; Bolaños JP; Almeida A
Neuropharmacology; 2019 Mar; 146():19-27. PubMed ID: 30452955
[TBL] [Abstract][Full Text] [Related]
8. Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death.
Chang KH; Vincent F; Shah K
J Cell Sci; 2012 Nov; 125(Pt 21):5124-37. PubMed ID: 22899714
[TBL] [Abstract][Full Text] [Related]
9. Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease.
Crews L; Patrick C; Adame A; Rockenstein E; Masliah E
Cell Death Dis; 2011 Feb; 2(2):e120. PubMed ID: 21368891
[TBL] [Abstract][Full Text] [Related]
10. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models.
Shi C; Viccaro K; Lee HG; Shah K
J Cell Sci; 2016 May; 129(9):1815-1830. PubMed ID: 28157684
[TBL] [Abstract][Full Text] [Related]
11. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
Lopes JP; Oliveira CR; Agostinho P
Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
[TBL] [Abstract][Full Text] [Related]
12. Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation.
Akhtar MW; Sanz-Blasco S; Dolatabadi N; Parker J; Chon K; Lee MS; Soussou W; McKercher SR; Ambasudhan R; Nakamura T; Lipton SA
Nat Commun; 2016 Jan; 7():10242. PubMed ID: 26743041
[TBL] [Abstract][Full Text] [Related]
13. Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity.
Sun KH; Chang KH; Clawson S; Ghosh S; Mirzaei H; Regnier F; Shah K
J Neurochem; 2011 Sep; 118(5):902-14. PubMed ID: 21668448
[TBL] [Abstract][Full Text] [Related]
14. S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease.
Bossy B; Petrilli A; Klinglmayr E; Chen J; Lütz-Meindl U; Knott AB; Masliah E; Schwarzenbacher R; Bossy-Wetzel E
J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S513-26. PubMed ID: 20463395
[TBL] [Abstract][Full Text] [Related]
15. Loss of mitofusin 2 links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells.
Park J; Choi H; Min JS; Kim B; Lee SR; Yun JW; Choi MS; Chang KT; Lee DS
J Neurochem; 2015 Mar; 132(6):687-702. PubMed ID: 25359615
[TBL] [Abstract][Full Text] [Related]
16. A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5).
Kaźmierczak A; Czapski GA; Adamczyk A; Gajkowska B; Strosznajder JB
Neurochem Int; 2011 Feb; 58(2):206-14. PubMed ID: 21130128
[TBL] [Abstract][Full Text] [Related]
17. Anti-diabetes drug pioglitazone ameliorates synaptic defects in AD transgenic mice by inhibiting cyclin-dependent kinase5 activity.
Chen J; Li S; Sun W; Li J
PLoS One; 2015; 10(4):e0123864. PubMed ID: 25875370
[TBL] [Abstract][Full Text] [Related]
18. The Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in a model of Alzheimer's disease.
Nikhil K; Shah K
J Cell Sci; 2017 Sep; 130(18):3023-3039. PubMed ID: 28751497
[TBL] [Abstract][Full Text] [Related]
19. Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction.
Sun KH; de Pablo Y; Vincent F; Shah K
J Neurochem; 2008 Oct; 107(1):265-78. PubMed ID: 18691386
[TBL] [Abstract][Full Text] [Related]
20. CDK5 phosphorylates DRP1 and drives mitochondrial defects in NMDA-induced neuronal death.
Jahani-Asl A; Huang E; Irrcher I; Rashidian J; Ishihara N; Lagace DC; Slack RS; Park DS
Hum Mol Genet; 2015 Aug; 24(16):4573-83. PubMed ID: 26002103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
